Ewan A Gibb

5PUBLICATIONS
45CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 22, 2025
Long non-coding RNAs define favourable biology in high-risk non-muscle-invasive bladder cancer.

Rachel Weng, Tran Anh Thu Phung, Robert Bell

|Jul 15, 2025
Molecular Characterization of Residual Muscle-Invasive Bladder Cancer Identifies a Scar-Like Transcriptomic Profile with Favorable Prognosis after Neoadjuvant Therapy.

Joep J de Jong, Moritz J Reike, Yair Lotan

|Oct 23, 2023
Genomic Tumor Correlates of Clinical Outcomes Following Organ-Sparing Chemoradiation Therapy for Bladder Cancer.

Sophia C Kamran, Yuzhen Zhou, Keisuke Otani

|Oct 03, 2022
Neoadjuvant Pembrolizumab and Radical Cystectomy in Patients with Muscle-Invasive Urothelial Bladder Cancer: 3-Year Median Follow-Up Update of PURE-01 Trial.

Giuseppe Basile, Marco Bandini, Ewan A Gibb

|Apr 22, 2022
Non-muscle-invasive micropapillary bladder cancer has a distinct lncRNA profile associated with unfavorable prognosis.

Joep J de Jong, Begoña P Valderrama, Julia Perera

Pageof 1